Should I buy or sell Pediatrix Medical Group stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pediatrix Medical Group in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" MD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MD, but not buy additional shares or sell existing shares. View MD analyst ratings or view top-rated stocks .

What is Pediatrix Medical Group's stock price target for 2024?

3 Wall Street analysts have issued 12-month price objectives for Pediatrix Medical Group's shares. Their MD share price targets range from $9.50 to $23.00. On average, they anticipate the company's share price to reach $15.30 in the next year. This suggests a possible upside of 82.6% from the stock's current price. View analysts price targets for MD or view top-rated stocks among Wall Street analysts .

How have MD shares performed in 2023?

Pediatrix Medical Group's stock was trading at $14.86 at the beginning of the year. Since then, MD shares have decreased by 43.6% and is now trading at $8.38. View the best growth stocks for 2023 here .

Are investors shorting Pediatrix Medical Group?

Pediatrix Medical Group saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 2,730,000 shares, a drop of 16.5% from the October 31st total of 3,270,000 shares. Based on an average daily volume of 560,900 shares, the short-interest ratio is presently 4.9 days. Currently, 3.3% of the company's stock are sold short. View Pediatrix Medical Group's Short Interest .

When is Pediatrix Medical Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, February 16th 2024. View our MD earnings forecast .

How were Pediatrix Medical Group's earnings last quarter?

Pediatrix Medical Group, Inc. (NYSE:MD) released its earnings results on Thursday, November, 2nd. The company reported $0.29 earnings per share for the quarter, missing analysts' consensus estimates of $0.40 by $0.11. The business had revenue of $506.60 million for the quarter, compared to the consensus estimate of $507.59 million. Pediatrix Medical Group had a net margin of 4.65% and a trailing twelve-month return on equity of 11.70%. Pediatrix Medical Group's revenue for the quarter was up 3.4% compared to the same quarter last year. During the same quarter last year, the business earned $0.37 EPS.

What ETFs hold Pediatrix Medical Group's stock?

ETFs with the largest weight of Pediatrix Medical Group (NYSE:MD) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS) , Invesco S&P SmallCap Health Care ETF (PSCH) , Roundhill Acquirers Deep Value ETF (DEEP) , Syntax Stratified SmallCap ETF (SSLY) and iShares U.S. Healthcare Providers ETF (IHF) . AdvisorShares Dorsey Wright Short ETF (DWSH) .

What is Mark S. Ordan's approval rating as Pediatrix Medical Group's CEO?

6 employees have rated Pediatrix Medical Group Chief Executive Officer Mark S. Ordan on Glassdoor.com . Mark S. Ordan has an approval rating of 34% among the company's employees. This puts Mark S. Ordan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Pediatrix Medical Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pediatrix Medical Group investors own include NVIDIA (NVDA) , AbbVie (ABBV) , QUALCOMM (QCOM) , Gilead Sciences (GILD) , Pfizer (PFE) , AT&T (T) , Walt Disney (DIS) , Wells Fargo & Company (WFC) , Exxon Mobil (XOM) and Advanced Micro Devices (AMD) .

Who are Pediatrix Medical Group's major shareholders?

Pediatrix Medical Group's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Earnest Partners LLC (6.07%), Charles Schwab Investment Management Inc. (1.77%), River Road Asset Management LLC (1.15%), Bank of New York Mellon Corp (0.91%), Invesco Ltd. (0.84%) and AQR Capital Management LLC (0.67%). Insiders that own company stock include James D Swift, John C Pepia , Mark S Ordan , Roger Mack Hinson , Roger Md Medel and Shirley A Weis. View institutional ownership trends .

How do I buy shares of Pediatrix Medical Group?

Shares of MD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Pediatrix Medical Group Stock Price, News & Analysis (NYSE:MD)

$8.38

-0.28 (-3.23%)

(As of 05:12 PM ET)

Compare

Today's Range: $8.22
▼
$8.67
50-Day Range: $8.64
▼
$12.98
52-Week Range: $8.22
▼
$17.30

Volume: 625,862 shs
Average Volume: 589,892 shs
Market Capitalization: $704.09 million

P/E Ratio: 7.42
Dividend Yield: N/A
Price Target: $16.75

Pediatrix Medical Group MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 82.6% Upside
$15.30 Price Target
Short Interest: Healthy
3.32% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 1.00
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 5.00%
From $1.20 to $1.26 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.83 out of 5 stars

Medical Sector

46th out of 949 stocks

Hospitals Industry

2nd out of 3 stocks

3.2

Analyst's Opinion

Consensus Rating
Pediatrix Medical Group has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $15.30, Pediatrix Medical Group has a forecasted upside of 82.6% from its current price of $8.38.
Amount of Analyst Coverage
Pediatrix Medical Group has only been the subject of 2 research reports in the past 90 days.

4.0

Short Interest

Percentage of Shares Shorted
3.32% of the float of Pediatrix Medical Group has been sold short.
Short Interest Ratio / Days to Cover
Pediatrix Medical Group has a short interest ratio ("days to cover") of 4.9.
Change versus previous month
Short interest in Pediatrix Medical Group has recently decreased by 16.51%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Pediatrix Medical Group does not currently pay a dividend.
Dividend Growth
Pediatrix Medical Group does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for MD.

2.8

News and Social Media Coverage

News Sentiment
Pediatrix Medical Group has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.75 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for Pediatrix Medical Group this week, compared to 2 articles on an average week.
Search Interest
1 people have searched for MD on MarketBeat in the last 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Pediatrix Medical Group insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 2.00% of the stock of Pediatrix Medical Group is held by insiders.
Percentage Held by Institutions
96.89% of the stock of Pediatrix Medical Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

3.8

Earnings and Valuation

Earnings Growth
Earnings for Pediatrix Medical Group are expected to grow by 5.00% in the coming year, from $1.20 to $1.26 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Pediatrix Medical Group is 7.42, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 117.46.
Price to Earnings Ratio vs. Sector
The P/E ratio of Pediatrix Medical Group is 7.42, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 99.36.
Price to Earnings Growth Ratio
Pediatrix Medical Group has a PEG Ratio of 0.63. PEG Ratios below 1 indicate that a company could be undervalued.
Price to Book Value per Share Ratio
Pediatrix Medical Group has a P/B Ratio of 0.73. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Pediatrix Medical Group Stock (NYSE:MD)

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

MD Stock Price History

30 days | 90 days | 365 days | Advanced Chart

MD Stock News Headlines

November 16, 2023 | finance.yahoo.com

Pediatrix Medical Group, Inc. (NYSE:MD) Shares Could Be 47% Below Their Intrinsic Value Estimate

November 16, 2023 | finance.yahoo.com

Miller Children's & Women's Announces New Miller Children's & Women's Neonatal Network in Partnership with Pediatrix Medical Group, Dr. Antoine Soliman Named Regional Medical Director

November 30, 2023 | Tomorrow Investor (Ad)

The Only Practical Solution to the World’s Looming Energy Crisis

There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!

November 10, 2023 | morningstar.com

Pediatrix Medical Group Inc MD

November 3, 2023 | msn.com

Pediatrix Medical Group (MD) Lags Q3 Earnings and Revenue Estimates

November 2, 2023 | finance.yahoo.com

Pediatrix Medical Group Inc (MD) Reports Q3 Earnings with Net Revenue of $507 Million

November 2, 2023 | msn.com

Pediatrix Medical Group Non-GAAP EPS of $0.32 misses by $0.11, revenue of $506.61M misses by $1.64M

October 31, 2023 | finance.yahoo.com

At US$11.41, Is Pediatrix Medical Group, Inc. (NYSE:MD) Worth Looking At Closely?

November 30, 2023 | Tomorrow Investor (Ad)

The Only Practical Solution to the World’s Looming Energy Crisis

There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!

October 27, 2023 | msn.com

How To Deal With Frequent Urination in Pregnancy

October 26, 2023 | finance.yahoo.com

Pediatrix Medical Group (MD) Reports Next Week: Wall Street Expects Earnings Growth

October 20, 2023 | finance.yahoo.com

Pediatrix Medical Group 2023 Third Quarter Conference Call/Webcast Scheduled for Thursday, November 2, 2023

October 1, 2023 | msn.com

What It Means When Your Vagina Smells Fishy, Metallic, or Just Plain Funky After Your Period

September 5, 2023 | finance.yahoo.com

Is Pediatrix Medical Group (MD) Too Good to Be True? A Comprehensive Analysis of a Potential ...

August 8, 2023 | seekingalpha.com

Pediatrix: Unable To Deploy Capital Tied Up In Cash Conversion Cycle, Reiterate Hold

August 4, 2023 | msn.com

Is Cardiac Arrest Common in Younger People, and Do Athletics Play a Role?

August 3, 2023 | washingtonpost.com

Pediatrix Medical Group: Q2 Earnings Snapshot

August 3, 2023 | msn.com

Pediatrix Medical Group (MD) Meets Q2 Earnings Estimates

July 31, 2023 | yahoo.com

Yes, You Can Get Pregnant If You're Already Pregnant—Here's How It Happens

July 27, 2023 | yahoo.com

How to Successfully Dream Feed Your Baby

July 18, 2023 | finance.yahoo.com

MD vs. PGNY: Which Stock Is the Better Value Option?

July 18, 2023 | finance.yahoo.com

Pediatrix Medical Group 2023 Second Quarter Conference Call/Webcast Scheduled for Thursday, August 3, 2023

June 1, 2023 | finance.yahoo.com

Why Is Pediatrix Medical Group (MD) Down 4.9% Since Last Earnings Report?

May 31, 2023 | fool.com

Pediatrix Medical Group (NYSE: MD)

May 24, 2023 | finance.yahoo.com

Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching

May 9, 2023 | nasdaq.com

Truist Securities Maintains Pediatrix Medical Group (MD) Hold Recommendation

May 6, 2023 | seekingalpha.com

Pediatrix: P&L Still Burdened From RCM Overhang, Reiterate Hold

See More Headlines

Receive MD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pediatrix Medical Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/02/2023
Today: 11/30/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 2/16/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Hospitals
Sub-Industry: Health Care Services
Sector: Medical
Current Symbol: NYSE:MD
Previous Symbol: NYSE:PDX
CUSIP: 58502B10
CIK: 893949
Web: www.mednax.com
Phone: (954) 384-0175
Fax: 954-838-9961
Employees: 5,250
Year Founded: 1979

Price Target and Rating

Average Stock Price Target: $15.30
High Stock Price Target: $23.00
Low Stock Price Target: $9.50
Potential Upside/Downside: +95.9%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): $1.13
Trailing P/E Ratio: 7.57
Forward P/E Ratio: 7.13
P/E Growth: 0.63
Net Income: $66.33 million
Net Margins: 4.65%
Pretax Margin: 5.88%
Return on Equity: 11.70%
Return on Assets: 4.67%

Debt

Debt-to-Equity Ratio: 0.64
Current Ratio: 1.20
Quick Ratio: 1.20

Sales & Book Value

Annual Sales: $1.97 billion
Price / Sales: 0.36
Cash Flow: $1.98 per share
Price / Cash Flow: 4.31
Book Value: $11.52 per share
Price / Book: 0.74

Miscellaneous

Outstanding Shares: 84,020,000
Free Float: 82,344,000
Market Cap: $718.37 million
Optionable: Optionable
Beta: 1.73

Social Links

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

Dr. James D. Swift M.D. (Age 61)
CEO & Director
Comp: $549.53k
Mr. C. Marc Richards (Age 52)
Executive VP & CFO
Comp: $509.58k
Ms. Mary Ann E. Moore (Age 63)
Executive VP, General Counsel & Secretary
Comp: $542.02k
Dr. Curtis B. Pickert M.D. (Age 65)
Executive VP & COO
Mr. John C. Pepia (Age 60)
Senior VP & Chief Accounting Officer
Comp: $931.2k
Ms. Cheryl M. VanPatten
Senior VP & Chief Information Officer
Mr. Daniel Patrick Corcoran
Senior Vice President of Administration & Managed Care
Mr. Charles W. Lynch C.F.A.
Senior VP of Finance, Strategy & Investor Relations
Ms. Meghan K. Lublin
Senior VP, Chief Brand & Communications Officer
Mr. Lee A. Wood (Age 55)
Executive Vice President of National & Market Operations

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

MD Stock Analysis - Frequently Asked Questions

Should I buy or sell Pediatrix Medical Group stock right now?: 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pediatrix Medical Group in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" MD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MD, but not buy additional shares or sell existing shares.
View MD analyst ratings or view top-rated stocks.
What is Pediatrix Medical Group's stock price target for 2024?: 3 Wall Street analysts have issued 12-month price objectives for Pediatrix Medical Group's shares. Their MD share price targets range from $9.50 to $23.00. On average, they anticipate the company's share price to reach $15.30 in the next year. This suggests a possible upside of 82.6% from the stock's current price.
View analysts price targets for MD or view top-rated stocks among Wall Street analysts.
How have MD shares performed in 2023?: Pediatrix Medical Group's stock was trading at $14.86 at the beginning of the year. Since then, MD shares have decreased by 43.6% and is now trading at $8.38.
View the best growth stocks for 2023 here.
Are investors shorting Pediatrix Medical Group?: Pediatrix Medical Group saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 2,730,000 shares, a drop of 16.5% from the October 31st total of 3,270,000 shares. Based on an average daily volume of 560,900 shares, the short-interest ratio is presently 4.9 days. Currently, 3.3% of the company's stock are sold short.
View Pediatrix Medical Group's Short Interest.
When is Pediatrix Medical Group's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, February 16th 2024.
View our MD earnings forecast.
How were Pediatrix Medical Group's earnings last quarter?: Pediatrix Medical Group, Inc. (NYSE:MD) released its earnings results on Thursday, November, 2nd. The company reported $0.29 earnings per share for the quarter, missing analysts' consensus estimates of $0.40 by $0.11. The business had revenue of $506.60 million for the quarter, compared to the consensus estimate of $507.59 million. Pediatrix Medical Group had a net margin of 4.65% and a trailing twelve-month return on equity of 11.70%. Pediatrix Medical Group's revenue for the quarter was up 3.4% compared to the same quarter last year. During the same quarter last year, the business earned $0.37 EPS.

What ETFs hold Pediatrix Medical Group's stock?: ETFs with the largest weight of Pediatrix Medical Group (NYSE:MD) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), Invesco S&P SmallCap Health Care ETF (PSCH), Roundhill Acquirers Deep Value ETF (DEEP), Syntax Stratified SmallCap ETF (SSLY) and iShares U.S. Healthcare Providers ETF (IHF).AdvisorShares Dorsey Wright Short ETF (DWSH).
What is Mark S. Ordan's approval rating as Pediatrix Medical Group's CEO?: 6 employees have rated Pediatrix Medical Group Chief Executive Officer Mark S. Ordan on Glassdoor.com. Mark S. Ordan has an approval rating of 34% among the company's employees. This puts Mark S. Ordan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Pediatrix Medical Group own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Pediatrix Medical Group investors own include NVIDIA (NVDA), AbbVie (ABBV), QUALCOMM (QCOM), Gilead Sciences (GILD), Pfizer (PFE), AT&T (T), Walt Disney (DIS), Wells Fargo & Company (WFC), Exxon Mobil (XOM) and Advanced Micro Devices (AMD).
Who are Pediatrix Medical Group's major shareholders?: Pediatrix Medical Group's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Earnest Partners LLC (6.07%), Charles Schwab Investment Management Inc. (1.77%), River Road Asset Management LLC (1.15%), Bank of New York Mellon Corp (0.91%), Invesco Ltd. (0.84%) and AQR Capital Management LLC (0.67%). Insiders that own company stock include James D Swift, John C Pepia, Mark S Ordan, Roger Mack Hinson, Roger Md Medel and Shirley A Weis.
View institutional ownership trends.
How do I buy shares of Pediatrix Medical Group?: Shares of MD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:MD) was last updated on 11/30/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial